Compare Smith & Nephew plc (SNN) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs VF Corp — how do they compare? Smith & Nephew plc trades at $27.24 (market cap $11.10B), while VF Corp trades at $15 (market cap $5.71B). The key difference: Smith & Nephew plc is the larger of the two by market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and VF Corp for 65 Days on average.
| SNN | VFC | |
|---|---|---|
Market Cap | $11.10B | $5.71B |
Volume | 1,051,703 | 8,987,330 |
Sector | Health | Consumer Cyclical |
52-Week High | $37.17 | $21.55 |
52-Week Low | $26.42 | $12.62 |
Typical Hold Time | 121 Days | 65 Days |
Enterprise Value | $14.13B | $10.00B |
Dividend Yield | 2.95% | 2.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Smith+Nephew (SNN) trades at $26.96, near its 52-week low, with bearish technical signals despite recent earnings beats. The company shows strong fundamentals with revenue growth to $6.16B in 2025 and improving profit margins of 10.08%. Recent product launches in trauma care and surgical robotics highlight innovation, but analyst sentiment remains cautious with 65% hold ratings.
Investment outlook is mixed: solid fundamentals and product pipeline offer upside, but technical weakness and analyst skepticism pose near-term risks. Key catalysts include execution on new product adoption and margin expansion, while risks involve competitive pressures and leadership transitions following the CFO's departure.
VFC trades at $14.53, up 1.04% with a bullish technical signal. The company shows mixed fundamentals with declining revenue from $11.8B in 2022 to $9.5B in 2025 and negative net income of -$189.72M, though 2026 projects a return to profitability. Analyst consensus is Hold with a $18.33 price target, representing 26% upside. Recent news highlights Vans brand weakness offset by Outdoor segment strength.
The outlook remains cautious with execution risk around the Vans turnaround being the key challenge. The discounted valuation (P/S 0.61) offers potential upside if management can stabilize operations, but persistent revenue declines and recent dividend cut signal ongoing headwinds. Risk-reward appears balanced near current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
